Lombard Medical(OTC) EVARF

Lombard Medical, Inc. is a medical technology firm focused on developing endovascular stent-grafts for aortic aneurysm repair. The company operates globally, with a strong presence in the United States, United Kingdom, Germany, and Japan.

Products and Services

• Aorfix: A stent-graft for abdominal aortic aneurysms with significant neck angulation
• Altura: An endovascular stent graft system for conventional AAA anatomies
• Aorflex and IntelliFlex LP: Advanced delivery systems for precise stent-graft deployment

Growth Outlook

• Global market for endovascular devices projected to grow significantly
• Increasing prevalence of aortic aneurysms driving demand for innovative solutions
• Expansion into new international markets enhances growth potential

Financial Highlights

• Market capitalization stands at approximately $2.8 million
• Current ratio of 3.33 indicates strong short-term financial health
• Cash per share is approximately $1.03, providing liquidity for operations

Lombard Medical, Inc. specializes in advanced medical devices, particularly in the treatment of aortic aneurysms. The company's flagship product, Aorfix, addresses complex anatomical challenges, positioning it well in a growing market. The global demand for endovascular devices is expected to rise, driven by an increasing incidence of aortic aneurysms. This trend, coupled with the company's strategic expansion into new markets, presents significant growth opportunities. Financially, Lombard Medical maintains a solid current ratio, indicating a robust ability to meet short-term obligations. The substantial cash reserves per share provide a cushion for operational needs and potential investments in research and development. Overall, Lombard Medical, Inc. represents a unique opportunity in the medical device sector, with innovative products and a favorable market outlook.